BioTuesdays

Category - Markets

IMAC-Logo

AGP cuts IMAC to neutral; PT to $1.75 from $2.35

Alliance Global Partners downgraded IMAC Holdings (NASDAQ:IMAC) to “neutral” and reduced its price target to $1.75 from $2.35 after the Center for Medicare and Medicaid Services (CMS) requested repayment of $2.9-million...

Amryt-Logo

SVB Leerink starts Amryt Pharma at OP: PT $22

SVB Leerink initiated coverage of Amryt Pharma PLC (NASDAQ:AMYT) with an “outperform” rating and price target of $22. Analyst Mani Foroohar, M.D., writes that Amryt’s model of acquiring niche commercial or near...

Portage Biotech Logo

Cantor starts Portage Biotech at OW; PT $35

Cantor Fitzgerald launched coverage of Portage Biotech (NASDAQ:PRTG) with an “overweight” rating and $35 price target. The stock closed at $18.95 on Aug. 18.  Portage Biotech is a clinical biopharmaceutical company...

HCW cuts Sesen Bio to neutral; withdraws PT

H.C. Wainwright downgraded Sesen Bio (NASDAQ:SESN) to “neutral” from “buy” and removed its price target after the company on Aug. 13 received a complete response letter from the FDA. The stock closed at $2.11 on Aug. 13...

RAPT-Therapeutics

SVB Leerink starts RAPT Therapeutics at OP; PT $49

SVB Leerink launched coverage of RAPT Therapeutics (NASDAQ:RAPT) with an “outperform” rating and a $49 price target. The stock closed at $33.07 on Aug. 11. RAPT is a clinical-stage biopharmaceutical company developing...

Sera Prognostics

WB starts Sera Prognostics at OP

William Blair launched coverage of Sera Prognostics (NASDAQ:SERA), a pregnancy diagnostics company, with an “outperform” rating. The stock closed at $12.85 on Aug. 6. Analyst Brian Weinstein writes that the current rate...